Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
June 24, 2010
Autosomal dominant acute necrotising encephalopathy: a case report with possible disease-expression modification by coincidental homocysteinuria
Clare Gilson, Robert McFarland, Rob Forsyth
The Practitioner
|
November 5, 2015
New developments in metastatic prostate cancer therapy
Thubeena Manickavasagar, Clare Gilson, Simon Chowdhury, et al.
European Urology
|
July 25, 2016
Repurposing Metformin as Therapy for Prostate Cancer within the STAMPEDE Trial Platform
Silke Gillessen, Clare Gilson, Nick James, et al.
Intractable & Rare Diseases Research
|
December 19, 2018
Uptake and radiological findings of screening cerebral magnetic resonance scans in patients with hereditary haemorrhagic telangiectasia
Gavin Fatania, Clare Gilson, Alan Glover, et al.
The Laryngoscope
|
April 24, 2016
Can Iron Treatments Aggravate Epistaxis in Some Patients With Hereditary Hemorrhagic Telangiectasia?
Claire L Shovlin, Clare Gilson, Mark Busbridge, et al.
JCO Oncology Practice
|
May 23, 2025
Management of Testicular Cancer
Daniele Raggi, Deep Chakrabarti, Walter Cazzaniga, et al.
Trials
|
May 30, 2019
This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols
Francesca Schiavone, Riya Bathia, Krishna Letchemanan, et al.
JCO Precision Oncology
|
January 20, 2022
Genomic Profiles of De Novo High- and Low-Volume Metastatic Prostate Cancer: Results From a 2-Stage Feasibility and Prevalence Study in the STAMPEDE Trial
Clare Gilson, Fiona Ingleby, Duncan C Gilbert, et al.
European Urology
|
August 27, 2019
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer
Alex P Hoyle, Adnan Ali, Nicholas D James, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2017
Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial
Malcolm D Mason, Noel W Clarke, Nicholas D James, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
June 24, 2010
Autosomal dominant acute necrotising encephalopathy: a case report with possible disease-expression modification by coincidental homocysteinuria
Clare Gilson, Robert McFarland, Rob Forsyth
The Practitioner
|
November 5, 2015
New developments in metastatic prostate cancer therapy
Thubeena Manickavasagar, Clare Gilson, Simon Chowdhury, et al.
European Urology
|
July 25, 2016
Repurposing Metformin as Therapy for Prostate Cancer within the STAMPEDE Trial Platform
Silke Gillessen, Clare Gilson, Nick James, et al.
Intractable & Rare Diseases Research
|
December 19, 2018
Uptake and radiological findings of screening cerebral magnetic resonance scans in patients with hereditary haemorrhagic telangiectasia
Gavin Fatania, Clare Gilson, Alan Glover, et al.
The Laryngoscope
|
April 24, 2016
Can Iron Treatments Aggravate Epistaxis in Some Patients With Hereditary Hemorrhagic Telangiectasia?
Claire L Shovlin, Clare Gilson, Mark Busbridge, et al.
JCO Oncology Practice
|
May 23, 2025
Management of Testicular Cancer
Daniele Raggi, Deep Chakrabarti, Walter Cazzaniga, et al.
Trials
|
May 30, 2019
This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols
Francesca Schiavone, Riya Bathia, Krishna Letchemanan, et al.
JCO Precision Oncology
|
January 20, 2022
Genomic Profiles of De Novo High- and Low-Volume Metastatic Prostate Cancer: Results From a 2-Stage Feasibility and Prevalence Study in the STAMPEDE Trial
Clare Gilson, Fiona Ingleby, Duncan C Gilbert, et al.
European Urology
|
August 27, 2019
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer
Alex P Hoyle, Adnan Ali, Nicholas D James, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2017
Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial
Malcolm D Mason, Noel W Clarke, Nicholas D James, et al.
Page
of 2